Braidwell »

Zura Bio shares owned by Braidwell

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Braidwell

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.2M 2.5M 2.50
2024-09-30 $10M 2.5M 4.06

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Novocure Note11/0 (Principal)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Cg Oncology (CGON)
Guardant Health (GH)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Align Technology (ALGN)
Dexcom Note 0.375% 5/1 (Principal)
Apogee Therapeutics (APGE)

View all positions for Braidwell

Top funds holding Zura Bio

Suvretta Capital Management
ADAR1 Capital Management
Deep Track Capital
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
Jpmorgan Chase & Co
Braidwell
Point72 Asset Management
VR Adviser
Armistice Capital
Stempoint Capital
Geode Capital Management
Vanguard Group
Millennium Management

View all funds holding Zura Bio